Y. Lopatin

发表

Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology

P. Ponikowski, G. Filippatos, L. Lund, 2020, European journal of heart failure.

Trimetazidine in cardiovascular medicine.

P. Ponikowski, A. Parkhomenko, P. Seferovic, 2019, International journal of cardiology.

The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network

M. Cowie, M. Volterrani, M. Trivi, 2022, International Journal of Cardiology.

Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

A. Cohen-Solal, L. Lund, P. Jhund, 2022, European journal of heart failure.

Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

F. Rutten, A. Strömberg, L. Lund, 2020, European journal of heart failure.

Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure

P. Ponikowski, G. Filippatos, L. Lund, 2020, European journal of heart failure.

Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology

G. Filippatos, A. Mebazaa, L. Lund, 2022, European journal of heart failure.

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

A. Cohen-Solal, L. Lund, P. Jhund, 2022, European journal of heart failure.

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

K. Anstrom, Mahesh J. Patel, P. Armstrong, 2021, Journal of the American Heart Association.

Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction

P. Ponikowski, M. Metra, P. Seferovic, 2021, European journal of heart failure.

Impact analysis of heart failure across European countries: an ESC‐HFA position paper

A. Bollmann, G. Filippatos, L. Lund, 2022, ESC heart failure.

Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology

P. Ponikowski, G. Filippatos, L. Lund, 2021, European journal of heart failure.

The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019

L. Lund, A. Coats, M. Lainscak, 2021, European journal of heart failure.

Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas

Ò. Miró, M. Metra, S. Collins, 2022, ESC heart failure.

Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology

A. Cohen-Solal, L. Lund, P. Jhund, 2022, European journal of heart failure.

European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure

P. Ponikowski, G. Filippatos, L. Lund, 2019, European journal of heart failure.

Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

K. Sliwa, I. Piña, S. Heymans, 2022, European journal of heart failure.

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

G. Filippatos, L. Lund, E. Arbustini, 2019, European journal of heart failure.

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

G. Filippatos, J. McMurray, A. Hoes, 2018, European journal of heart failure.

The Heart Failure Association Atlas: rationale, objectives, and methods

P. Vardas, A. Coats, P. Seferovic, 2020, European journal of heart failure.

Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document

G. Filippatos, A. Coats, P. Seferovic, 2020, European journal of heart failure.

Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC

A. Cohen-Solal, G. Filippatos, A. Mebazaa, 2023, European journal of heart failure.

The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians

A. Mebazaa, A. Coats, P. Seferovic, 2020, ESC heart failure.

Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy

K. Sliwa, P. Armstrong, V. Melenovský, 2023, European journal of heart failure.

State‐of‐the‐art document on optimal contemporary management of cardiomyopathies

K. Sliwa, G. Filippatos, A. Keren, 2023, European journal of heart failure.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies

G. Filippatos, B. Bozkurt, P. Seferovic, 2023, European journal of heart failure.